Detection and effective treatment of childhood TB in Kyrgyzstan and development of national TB programme


A team of WHO experts visited Kyrgyzstan on 8–11 August 2016 to provide technical assistance in the adaptation and scale up of new recommendations on fixed-dose combinations for the treatment of tuberculosis (TB) in children, issued by WHO in March 2016. The team also analysed the country’s existing clinical protocol and reviewed the current diagnostic and treatment algorithm, including indications for preventive treatment, as a follow-up to the WHO midterm programme review of the country’s TB prevention, control and care activities conducted in 2014.

WHO staff and key partners from the Ministry of Health, national TB and HIV programmes, and the United States Agency for International Development projects on TB participated in a roundtable consultation on revised national clinical protocol on childhood TB. The WHO staff were Dr Martin van den Boom, Technical Officer, TB and Multidrug- and Extensively Drug-resistant TB at WHO/Europe; Dr Jarno Habicht, WHO Representative to Kyrgyzstan; and Dr Iveta Ozere, WHO consultant.

A working group, led by WHO experts, has collated all valuable inputs and comments including from experts working on:

  • infection control
  • contact tracing in households
  • adverse effects after bacille Calmette–Guérin vaccination
  • implementation of new drugs
  • fixed-dose combinations in treatment of TB in children.

WHO also provided technical assistance in elaborating the new State TB programme and aligning it with the TB action plan for the WHO European Region 2016–2020. The team reviewed the draft document and shared with partners that more focus should be placed on governance and health financing so Kyrgyzstan can continue its progress in the Global Fund to Fight AIDS, TB and Malaria’s country graduation process. The WHO team will also provide technical assistance on health systems strengthening within the WHO Regional Project for Eastern Europe and Central Asia countries (TB-REP) supported by the Global Fund.

All available WHO strategic documents, guidelines and materials have been shared with all national and international partners in the country.